Patients suffering from epilepsy experience better health outcomes—with fewer adverse side effects—when they use plant-based cannabidiol (CBD) extracts compared to “purified” CBD products, according to a new scientific review. A team of Brazilian researchers conducted a meta-analysis of studies from 2013 to 2017 that have explored the therapeutic benefits of CBD for epilepsy patients. The […]| Marijuana Moment
The U.S. Department of Agriculture (USDA) is encouraging hemp growers to construct a Ghostbusters-like backpack vacuum that will allow them to collect up to 10 grams of cannabis pollen in less than a minute. It’s part of an effort to gather and distribute the pollen to an international group of researchers and breeders. In an […]| Marijuana Moment
As the U.S. Department of Agriculture (USDA) works to rebuild a government seed bank for hemp that was destroyed during prohibition, the agency is issuing updated guidance on how to identify, describe and evaluate different varieties of the plant. USDA’s latest version of its Hemp Descriptor and Phenotyping Handbook, released earlier this summer, is the […]| Marijuana Moment
Researchers published more than 4,300 studies on marijuana and its components in 2022—an new annual record—an analysis from NORML shows. “We need more research” is easily one of the most common refrains from reform opponents, who insist that cannabis is understudied despite the fact that it’s one of the most frequently researched medical subjects. To […]| Marijuana Moment
While many marijuana enthusiasts believe that components called terpenes are responsible for strains’ distinctive smells, a new study published by the American Chemical Society has identified “previously undiscovered cannabis compounds” that challenge that conventional wisdom of what really gives each variety its unique olfactory profile. The research, conducted by a team of scientists from marijuana […]| Marijuana Moment
More than three months after news leaked that the U.S. Health and Human Services Department (HHS) was recommending that marijuana be moved to Schedule III under the federal Controlled Substances Act (CSA), the agency has finally released a tranche of documents related to its recommendation and the detailed review it undertook on cannabis’s accepted medical […]| Marijuana Moment